Multienzymatic biotransformation of flavokawain B by entomopathogenic filamentous fungi: structural modifications and pharmacological predictions

Paweł Chlipała,Tomasz Tronina,Monika Dymarska,Monika Urbaniak,Ewa Kozłowska,Łukasz Stępień,Edyta Kostrzewa-Susłow,Tomasz Janeczko
DOI: https://doi.org/10.1186/s12934-024-02338-9
IF: 6.352
2024-02-26
Microbial Cell Factories
Abstract:Flavokawain B is one of the naturally occurring chalcones in the kava plant ( Piper methysticum ). It exhibits anticancer, anti-inflammatory and antimalarial properties. Due to its therapeutic potential, flavokawain B holds promise for the treatment of many diseases. However, due to its poor bioavailability and low aqueous solubility, its application remains limited. The attachment of a sugar unit impacts the stability and solubility of flavonoids and often determines their bioavailability and bioactivity. Biotransformation is an environmentally friendly way to improve the properties of compounds, for example, to increase their hydrophilicity and thus affect their bioavailability. Recent studies proved that entomopathogenic filamentous fungi from the genera Isaria and Beauveria can perform O -methylglycosylation of hydroxyflavonoids or O -demethylation and hydroxylation of selected chalcones and flavones.
biotechnology & applied microbiology
What problem does this paper attempt to address?